Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Pharmaxis.
RELATED STOCKHEAD STORIES
News
Last Orders: ASX begins FY22 down 0.65 per cent
Health & Biotech
Dr Boreham’s Crucible: Why is Pharmaxis’ valuation so ‘pitiful’? Karst Peak doesn’t know either
News
Trading Places: Tolga Kumova has upped his stake in uranium play Valor Resources (ASX:VAL)
News
Last Orders: ASX crosses 7,000 point mark
News
Last Orders: ASX back in the green as ‘risk on’ sentiment returns
News
Market highlights and 5 ASX small caps to watch on Friday
News
Last Orders: ASX small caps up as large caps lag
Health & Biotech
The cheque has arrived: Pharmaxis gets $9.2 million payday
News
Trading Places: Alex Waislitz’s Thorney Opportunities chipped in to these ASX stocks
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Investors could be in the eye of a storm
Health & Biotech
Pharmaxis to get $14m payday after its cystic fibrosis treatment Bronchitol approved by FDA
News
10 at 10: These ASX stocks are ascending from the horizon this morning
Experts
ScoPo’s health powerplays: Pot stocks get a boost
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Have markets stabilised after that ‘quick and severe’ correction?
Health & Biotech
